Supernus Pharmaceuticals
SUPN
#4323
Rank
HK$15.65 B
Marketcap
HK$283.51
Share price
0.88%
Change (1 day)
33.06%
Change (1 year)

EPS for Supernus Pharmaceuticals (SUPN)

EPS in 2023 (TTM): HK$6.18

According to Supernus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is HK$6.14. In 2022 the company made an earnings per share (EPS) of HK$8.78 an increase over its 2021 EPS that were of HK$7.92.

EPS history for Supernus Pharmaceuticals from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$6.18-29.56%
2022HK$8.7810.78%
2021HK$7.92-57.68%
2020HK$18.7212.09%
2019HK$16.700.47%
2018HK$16.6389.38%
2017HK$8.78-38.59%
2016HK$14.30534.48%
2015HK$2.25-211.54%
2014-HK$2.02-91.1%
2013-HK$22.6939.46%
2012-HK$16.27-69.27%
2011-HK$52.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$150.11 2,345.57%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$42.18 587.25%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$30.84 402.53%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$23.09 276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$109.43 1,682.95%๐Ÿ‡บ๐Ÿ‡ธ USA